Pyrazolone-derivatives and their use as PDE-4 inhibitors
US9340522B2 · kind B2 · utility
0Cited by
11References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 15, 2013 |
| Grant date | May 17, 2016 |
| Priority date | — |
| Expiry date | May 10, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The compounds of Formula (I),are novel effective inhibitors of the type 4 phosphodiesterase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.